Bayer Healthcare to obtain Pathway Medical Technologies Bayer Health care announced today that it is affiliate, MEDRAD, Inc nizagara kaufen nizagara100mg.net . Has obtained Pathway Medical Technology, Inc., of Kirkland, Clean. Financial conditions of the agreement weren’t disclosed. With this acquisition, Bayer Health care is certainly strengthening its MEDRAD Interventional business by growing its presence in neuro-scientific vascular intervention technology. Pathway Medical Technology is a innovator in mechanical atherectomy in neuro-scientific vascular intervention. The business’s products drive out blockages in the leg, referred to as Peripheral Arterial Disease or PAD also.
Bayer Schering Pharma to build up new BiTE antibody for treatment of stable tumors Micromet, Inc. , a biopharmaceutical firm developing novel, proprietary antibodies for the treating cancer, today announced that Bayer Schering Pharma AG provides exercised its option beneath the option swelling and autoimmune diseases, collaboration and license contract entered into on January 12, 2009 to develop a fresh BiTE antibody for the treating solid tumors. Beneath the conditions of the agreement, Bayer Schering Pharma had a choice until January 5, 2010 to permit a particular BiTE antibody targeting an undisclosed focus on. The option workout triggers a formal collaboration between Micromet and Bayer Schering Pharma on the advancement of the BiTE antibody.